Dr. Sumrow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Manning Dr
Cb#7010, Room N2201
Chapel Hill, NC 27514Phone+1 919-966-5136Fax+1 919-966-4873- Is this information wrong?
Education & Training
University of North Carolina HospitalsResidency, Anesthesiology, 2010 - 2014
University of North Carolina at Chapel Hill School of MedicineClass of 2010
Certifications & Licensure
NC State Medical License 2015 - 2025
Clinical Trials
- MGD019 DART® Protein in Unresectable/Metastatic Cancer Start of enrollment: 2018 Dec 12
Publications & Presentations
PubMed
- 7 citationsThe PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.Jason J Luke, Manish R Patel, George R Blumenschein, Erika Hamilton, Bartosz Chmielowski, Susanna V Ulahannan, Roisin M Connolly, Cesar A Santa-Maria, Jie Wang, Shakee...> ;Nature Medicine. 2023 Nov 1
- 32 citationsDevelopment and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule.Alexey Berezhnoy, Bradley James Sumrow, Kurt Stahl, Kalpana Shah, Daorong Liu, Jonathan C. Li, Su-Shin Hao, Anushka De Costa, Sanjeev Kaul, Johanna C. Bendell, Gregory...> ;Cell Reports. Medicine. 2020 Dec 22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
